PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21430794-0	2011	Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation.	Duloxetine Hydrochloride	95-105	interleukin 6	Homo sapiens	12-16	
26556688-4	2015	RESULTS: IL-6 variants rs2066992 and rs10242595 were nominally associated with response to duloxetine (p = 0.047 and p = 0.028, respectively).	Duloxetine Hydrochloride	91-101	interleukin 6	Homo sapiens	9-13	
26556688-7	2015	CONCLUSION: Our findings tentatively suggest that IL-6 variants play a role in duloxetine and placebo response, which warrants further investigation.	Duloxetine Hydrochloride	79-89	interleukin 6	Homo sapiens	50-54	
21430794-9	2011	Nonetheless, the trend of increasing IL-6 levels observed in responder patients treated with duloxetine should prompt further controlled, extended studies with larger samples, with the specific aim of better assessing a putative differential role of norepinephrinergic antidepressant stimulation of serotonergic reuptake inhibition in determining modifications in IL-6 levels.	Duloxetine Hydrochloride	93-103	interleukin 6	Homo sapiens	37-41	
21430794-9	2011	Nonetheless, the trend of increasing IL-6 levels observed in responder patients treated with duloxetine should prompt further controlled, extended studies with larger samples, with the specific aim of better assessing a putative differential role of norepinephrinergic antidepressant stimulation of serotonergic reuptake inhibition in determining modifications in IL-6 levels.	Duloxetine Hydrochloride	93-103	interleukin 6	Homo sapiens	364-368